President ' ’s $ 215 million investment in the Precision Medicine Initiative illustrates the emphasis placed on personalising care in the fight against cancer . Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. . Most recently the increase in targeted therapies , using kinase ##s and monoclonal antibodies , has allowed for therapy personalisation in an increasing numbers of cancer patients . Despite this , curative treatments for advanced malignant tumours are uncommon .
President ' ’s $ 215 million investment in the Precision Medicine Initiative illustrates the emphasis placed on personalising care in the fight against cancer . Most recently the increase in targeted therapies , using kinase ##s and monoclonal antibodies , has allowed for therapy personalisation in an increasing numbers of cancer patients . Despite this , curative treatments for advanced malignant tumours are uncommon .